GRAPEFRUIT - 54575-399-30 - (grapefruit)

Alphabetical Index


Drug Information of GRAPEFRUIT

Product NDC: 54575-399
Proprietary Name: GRAPEFRUIT
Non Proprietary Name: grapefruit
Active Ingredient(s): 1    g/20mL & nbsp;   grapefruit
Administration Route(s): PERCUTANEOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of GRAPEFRUIT

Product NDC: 54575-399
Labeler Name: Allergy Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102192
Marketing Category: BLA
Start Marketing Date: 19720829

Package Information of GRAPEFRUIT

Package NDC: 54575-399-30
Package Description: 30 mL in 1 VIAL, MULTI-DOSE (54575-399-30)

NDC Information of GRAPEFRUIT

NDC Code 54575-399-30
Proprietary Name GRAPEFRUIT
Package Description 30 mL in 1 VIAL, MULTI-DOSE (54575-399-30)
Product NDC 54575-399
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name grapefruit
Dosage Form Name INJECTION, SOLUTION
Route Name PERCUTANEOUS; SUBCUTANEOUS
Start Marketing Date 19720829
Marketing Category Name BLA
Labeler Name Allergy Laboratories, Inc.
Substance Name GRAPEFRUIT
Strength Number 1
Strength Unit g/20mL
Pharmaceutical Classes Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Dietary Proteins [Chemical/Ingredient],Fruit Proteins [Chemical/Ingredient]

Complete Information of GRAPEFRUIT


General Information